The Society for Immunotherapy of Cancer (SITC) hosted Session 107c during the 39th Annual Meeting & Pre-Conference Programs on Friday, November 8, 2024. Available here are the presentation slides and video from “Session 107c: Timing and Combination of Systemic Therapies in Solid Cancers” as permitted by presenters.
Diwakar Davar, MD – UPMC Hillman Cancer Center
Sherene Loi, MD, PhD – Peter MacCallum Cancer Centre
This session will explore how the underlying biology of combination therapies in solid tumors and how those combinations may change and overcome specific mechanisms of resistance to immune therapy in a spectrum of malignancies. The Session also aims to discuss provocative questions concerning novel combination immunotherapeutic development armed with a deeper biological understanding of how rational combinations and sequences of therapies can overcome specific resistance mechanisms, attendees will be equipped to design effective clinical trials leading to better patient outcomes.
To view the entire program schedule (including presenter permission to post) please click here.
01:15:47